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Abstract
Background: Although hypertension is highly prevalent in Nigeria, coronary artery disease (CAD) remains
relatively uncommon. This may well change due to epidemiological transition. To ascertain the future role of CAD in
Nigeria, we risk stratified every consecutive hypertensive subject referred to the Cardiology unit of the University of
Abuja Teaching Hospital over 7 years.
Hypothesis: A significant proportion of the study population will fall within the intermediate or high risk category.
Methods: It is a prospective, observational study. 1571 hypertensive subjects were risk stratified according to the
Framingham 10-year Risk Score.
Results: 834(53.1%) of the subjects were female while 737(46.9%) were male. The mean age, mean body mass
index and mean arterial pressure of the subjects were 50.9 ± 11.4 years, 28.1 ± 9.4 kg/m2 and 116.23 ± 13.1 mmHg
respectively. According to Framingham criteria, 1263(80.4%) of the study population were low risk individuals,
286(18.2%) were medium risk, 22(1.4%) were high risk individuals. When the age of the subjects was hypothetically
increased by an additional 10 years, the high risk group increased from 1.3% to 21.3%.
Conclusions: According to the Framingham risk score, the majority of subjects with hypertension presenting to a
large teaching hospital in Nigeria have a low risk of developing CAD in the near future, which contrasts with the risk
profile seen in hypertensive subjects in Europe and North America. Nonetheless, approximately one in four subjects
were classified as intermediate or high risk emphasizing the importance of lifestyle modification and the need to
consider absolute risk stratification to guide management in countries undergoing epidemiological transition.
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Introduction
Despite a relatively high prevalence of hypertension in Nigeria
(estimated to affect 25-27% of the population) [1], and the high burden
of hypertensive left ventricular hypertrophy [2-6], hypertensive heart
failure [7-10], chronic kidney disease [11-16] and strokes [17,18] due
to uncontrolled hypertension, the prevalence of coronary artery
disease (CAD) is still relatively low [19,20].
This represents a paradox given that each 20 mmHg increase in SBP
over the range of 115-185 mmHg doubles coronary heart disease and
stroke mortality [21]. Consequently, in clinical trials, anti-hypertensive
therapy is associated with a 20-25% reduction in incident myocardial
infarction [22]. Furthermore, a 10 to 12 mmHg reduction in systolic
blood pressure and a 5 to 6 mmHg reduction in diastolic blood
pressure has been shown to reduce the risk of coronary artery disease
(CAD) by 16% [21]. It has however, been projected that with the
epidemiological transition in disease pattern being experienced in
many parts of sub-Saharan Africa [23], CAD is likely to play a more
significant role in the burden of disease in Nigeria in the future.
To ascertain the future role of CAD in Nigeria, we risk stratified
consecutive hypertensive subjects undergoing specialist cardiology
review in a major tertiary referral hospital in Nigeria, according to 10
year Framingham risk criteria.
Methods
Subjects
We prospectively studied every consecutive patient referred for the
first time to the Cardiology Clinic of the University of Abuja Teaching
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Hospital with a diagnosis of hypertension from April 2006 to August
2013. These patients were typically referred by General and Family
Physicians in Primary and Secondary Healthcare facilities including
both the public and private sector. The patients included public
servants, traders, businessmen, politicians, farmers, artisans and
retired public servants. A total of 2275 subjects were recruited for the
study with an average recruitment of 28 per month. Subjects with
established cardiovascular disease including prior documented stroke,
coronary artery disease, heart failure and chronic kidney disease which
represented 30% of the total subjects recruited were excluded from the
study. This left 1571 hypertensive subjects with no documented
vascular disease or chronic kidney disease at baseline, of whom
110(7%) were diabetic.
Study data
Using a standardized questionnaire, baseline demographic and
clinical characteristics of patients were obtained. In order to minimize
selection bias, data were collected on a consecutive patient basis.
Information obtained from the patients included gender, age, prior
history of hypertension or diabetes mellitus and family history of
hypertension or diabetes mellitus. Other information collected was
past or present history of myocardial infarction, angina pectoris,
stroke, heart failure and renal failure. Pharmacological treatment was
determined by the treating clinician.
Each subject had a complete physical examination including height
and weight measurements. Blood pressure measurement was according
to standard guidelines with a mercury sphygmomanometer (Accosson,
London, UK). Systolic and diastolic blood pressures was measured
using Korotkof sounds I and V. Blood pressure was measured at the
right arm three times, with a 5 minute rest between each measurement.
The diagnosis of hypertension was made when the average of three
blood pressure measurements was ≥ 140/90 mmHg or the subject had
been previously diagnosed with hypertension and was on anti-
hypertensive therapy. Subjects were asked to fast for 8-12 hours before
blood sample collection. Blood chemical analysis was performed at a
certified central laboratory. Fasting blood glucose and lipids were
analysed enzymatically by auto analyzer (Erber Spectrophotometer).
This study complied with the Declaration of Helsinki and all
participants provided written informed consent and the study was
approved by the University of Abuja Teaching Hospital Ethics
Committee.
Framingham risk
The specific 10-year risk of CAD was calculated (as a specific
percentage score) in all the subjects according to the Framingham Risk
Stratification algorithm including age, gender, total and high-density
lipoprotein-cholesterol, systolic blood pressure, and cigarette smoking.
Subjects were then classified as <10% (low risk), 10-20% (intermediate
risk) and >20% (high risk). The Framingham risk score has been found
to perform well in African Americans which is a population that has
the same ancestry origin as our subjects [24].
Data analysis
SPSS software version 16.0 (SPSS Inc, Chicago, IL) was used for
statistical analysis. Continuous variables were expressed as mean ±SD.
We compared the distribution of the three risk groups and related the
distribution to the sex of the subjects and the presence or absence of
diabetes mellitus. We also compared the demographic and clinical
characteristics of the subjects using student t-test. A 2-tailed p
value<0.05 was considered significant.
Results
Demographic and clinical characteristics of the subjects
Table 1 shows the demographic and clinical characteristics of the
subjects and also by gender. This was a predominantly middle-aged
cohort (mean age 50.1 ± 12.6 years), 53% women and predominantly
overweight (mean BMI 28.9 ± 6.7 kg/m2).
Females were slightly younger than their male counterparts (49.5 ±
12.9 years versus 50.8 ± 12.1 years, p=0.03). They also smoked less than
their male counterparts (0.9% versus 13.3% p<0.0001). Female subjects
had higher body mass index, total cholesterol and triglyceride levels
(30.4 ± 7.0 kg/m2 versus 27.3 ± 5.8 kg/m2, p<0.0001, 5.3 ± 1.3 mmol/L
versus 4.9 ± 1.2 mmol/L, p<0.0001 and 2.1 ± 0.77 mmol/L versus 1.0 ±
0.30 mmol/L, p<0.0001). Blood pressures were similar in men and
women.
Distribution of risk stratification in all the subjects
Figure 1 shows the distribution of risk stratification in the 1591
subjects. 1263(80.4%) were classified low risk, 286(18.2%) moderate
risk and 22(1.4%) high risk of CAD events within 10 years.
Variables ALL (N=1571) Males
(N=737)
Females
(N=834)
P-value
Age (Years) 50.1 ± 12.6 50.8 ± 12.1 49.5 ± 12.9 0.03
Smoking Habits 13.3 0.9 <0.0001
Systolic Blood Pressure (mmHg) 153.4 ± 25.1 156.1 ± 25.3 152.7 ± 25.0 0.28
Diastolic Blood Pressure (mmHg) 95.2 ± 15.7 95.9 ± 16.1 94.3 ± 15.3 0.09
Mean Arterial Pressure(mmHg) 107.1 ± 18.6 110.4 ± 19.1 109.9 ± 19.9 0.63
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Body Mass Index (mmHg) 28.9 ± 6.7 27.3±5.8 30.4±7.0 <0.0001
Total Cholesterol (mmol/L) 5.0 ± 1.2 4.9 ± 1.2 5.3 ± 1.3 <0.0001
LDL Cholesterol (mmol/L) 3.2 ±1.2 3.2 ± 1.1 3.3 ± 1.3 0.59
HDL Cholesterol (mmol/L) 1.2 ± 0.51 1.0 ± 0.49 1.3 ± 0.56 0.44
Triglyceride (mmol/L) 1.3 ± 0.69 1.0 ± 0.30 2.1 ± 0.77 <0.0001
Urea(mmol/L) 5.5 ± 2.7 5.2 ± 1.4 5.9 ± 1.5 0.05
Creatinine (µmol/L) 103.0 ± 20.8 99.8 ± 47.8 109.0 ± 47.2 0.12
Packed Cell Volume (%) 39.7 ± 5.4 41.3 ± 6.2 38.0 ± 5.2 <0.0001
White Blood Count 5.9 ± 2.3 5.9 ± 2.7 5.9 ± 1.7 0.69
Table 1: Demographic and clinical characteristics of all the subjects by gender.
Figure 1: Framingham risk stratification in all the subjects.
Distribution of risk stratification in all the subjects
Figure 1 shows the distribution of risk stratification in the 1591
subjects. 1263(80.4%) were classified low risk, 286(18.2%) moderate
risk and 22(1.4%) high risk of CAD events within 10 years.
Table 2 shows the increasing trend in the proportion of subjects
classified in the highest risk category when the average age of the
cohort is hypothetically increased by 5 years at a time to a maximum of
10 years. The high risk category increased from 1.3% to 21.3% when 10
years was added to the original age of subjects.
Figure 2: Framingham risk stratification in the subjects by gender.
Distribution of risk stratification in the subjects by gender
Figure 2 shows the distribution of risk stratification in the subjects
by gender. The male subjects had a higher proportion classified as
moderate and high risk compared to the female subjects (34.4% versus
5.9%, p<0.0001 and 2.6% versus 0.3%, p=0.0002 respectively), and had
a lower proportion of those classified as low risk (63.0% versus 94.8%,
p < 0.0001).
FRS Normal Age
N=1571
Age+5years
N=1571
Age+10years
N=1571
Low 1,263(80.4%)**,*** 1,178(75.0)*** 819(52.1%)
Moderate 286(18.2%) 240(15.3%) 417(26.6%)*, **
High 22(1.4%) 153(9.7%) 334(21.3%)*, **
*= significantly higher than those with Normal Age, **= significantly higher than those with Age+5year,***= significantly higher than those with Age+10years, P-value less
than 0.05 is significant.
Table 2: Comparison of framingham risk score in the cohort with progressive ages.
Citation: Ojji D, Stewart S, Atherton J, Ajayi S, Mamven M, et al. (2016) Ten-Year Coronary Artery Disease Risk in 1571 Newly Presenting
Hypertensive Black Subjects. J Community Med Health Educ 6: 442. doi:10.4172/2161-0711.1000442
Page 3 of 5
J Community Med Health Educ
ISSN:2161-0711 JCMHE, an Open Access Volume 6 • Issue 3 • 1000442
Framingham risk classification in diabetic and non-diabetic
subjects
Figure 3 shows that the proportion of the diabetic subjects classified
as high risk was significantly higher than that of the non-diabetic
subjects (7.7% versus 1.3%, p=0.004), while there was no significant
difference in proportions classified in the low and moderate risk
categories.
Discussion
Consistent with a relatively low prevalence of CAD in Nigeria,
amongst a large cohort of individuals with newly diagnosed
hypertension, we found that only 1.3% of our subjects were classified as
being at high risk of developing CAD in the next ten years according to
Framingham criteria. The remainders were either at intermediate
(approximately one quarter) or low risk (approximately three quarters
of the cohort) for such an outcome.
Figure 3: Framingham risk stratification in diabetic versus non-
diabetic subjects.
These data contrast with that reported by Wong and colleagues [25]
who reported that 55% of hypertensive subjects were classified as high
risk using the Framingham Risk Score in American subjects, and an
Italian study where approximately 60% were classified as high risk
based on European guidelines [26]. It is also much lower than the
findings of Fagard et al. [27] who showed that 39.6% of subjects with
isolated systolic hypertension were classified as high risk as compared
to 68.4% of subjects with diastolic hypertension. The much lower risk
of developing CAD in our subjects compared to Caucasians and Asians
is not surprising as our subjects have been shown previously to have a
lower prevalence of cardio metabolic risk factors [28], compared to
Caucasians [29] and Asians [30]. A diet that is lower in saturated fat
and rich in vegetables might also be contributory to the lower risk in
our subjects [23]. Furthermore, our subjects were younger than other
hypertensive cohorts, however this is unlikely to completely explain the
much lower risk of CAD observed in our cohort. Indeed, when the age
of our cohort was hypothetically increased by an additional 10 years
(similar to the average age reported by Mancia et al. in an Italian
hypertensive cohort in which 55% were classified as high risk), only
21% of subjects were classified as high risk. Whilst this admittedly
assumes that other risk factors remain the same, given that age is the
major driver of absolute risk, it implies that our cohort has a
substantially lower risk driven by the low prevalence of other
cardiovascular risk factors.
Our female subjects were at lower risk of developing coronary artery
disease compared to male subjects similar to previous report [31]. This
is most likely due to the younger age and higher smoking rates in men.
The female subjects were however found to have higher total
cholesterol and triglyceride levels, similar to previous report in African
Americans [32]. We found our diabetic subjects to be at a higher risk
of developing coronary artery disease when compared to non-diabetic
subjects. This finding is not surprising as diabetes mellitus is a strong
risk factor for ischemic heart disease [32-34].
With recent westernization and improvements in the control of
infectious diseases in most parts of Sub-saharan Africa, life expectancy
in Nigeria is most likely going to increase. Such an increase in the
aging population fuelled by changing diet from westernization means
that a higher proportion of our hypertensive subjects will develop
CAD in the near future. This will mean triple burden of cardiovascular
disease from not only hypertensive heart failure and stroke but also
from coronary artery disease.
Therefore, apart from increasing public health education on life
style modification to stem the trend of changing lifestyle and diet,
there might be the need for additional catheterization laboratories
(presently there are only two publicly run catheterization laboratories
in Nigeria). This will obviously involve planning and appropriation of
resources especially in the face of increasing burden of hypertensive
heart failure and stroke in this population group [35].
Limitations of the Study
Since Framingham Risk Score was used to risk stratify our subjects,
BMI was not taken into account. In addition, risk factors such as family
history of premature cardiovascular disease, obesity, high sensitivity C-
reactive protein, homocysteine, cytokines, hypertriglyceridemia,
impaired glucose tolerance and obesity were not taken into account.
There would have also been under estimation of risk score in subjects
with severe hypertension (systolic blood pressure >180 mmHg and/or
DBP>110 mmHg) or associated target organ damage. However, the
fact that Framingham risk score is the only risk score that has been
validated in African Americans who have the same ancestry origin as
our subjects makes it the most suitable risk scoring system for our
subjects.
Conclusion
Whilst the risk of developing coronary artery disease in
hypertensive subjects presenting to a major teaching hospital in
Nigeria appears to be substantially lower compared to European and
North American cohorts, one in four subjects were nonetheless
classified as intermediate or high risk. This emphasizes the need to
address emerging risk factors including smoking and obesity, and the
need to consider absolute risk to guide treatment decisions in countries
undergoing epidemiological transition.
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